Find Academic Supervisors

Kristian LarsenView profile

Professor

• Health research
• Sociology of healthcare
• Educational research
• +6 more

Kristian Larsen serves as Professor at the Department of Public Health within the Faculty of Health and Medical Sciences at University of Copenhagen. His scholarly work integrates health research, sociology, and educational methodologies, with particular emphasis on applying Pierre Bourdieu's relational thinking to analyze healthcare institutions, professional practices, and patient relationships. His research has made significant contributions to understanding health inequality within Nordic contexts, especially in Norway. Education: Ph.D. awarded June 30, 2000 Larsen's research program spans health services research, medical sociology, and educational theory. He specializes in Bourdieu's theoretical framework to examine how social structures influence healthcare delivery and health outcomes. His work demonstrates how institutional practices, professional hierarchies, and patient experiences interact within healthcare systems. He has extensive experience teaching the integration of theoretical frameworks with research methods and empirical data analysis in health sciences. His recent publications (2023-2025) reveal three dominant research trajectories: immigrant healthcare professionals in Nordic systems, neuroscience applications of psychedelic substances, and community-based rehabilitation practices. These works employ diverse methodologies including qualitative analysis, scoping reviews, and neuroimaging techniques, demonstrating his interdisciplinary approach across public health, social science, and clinical research domains. Larsen leads the Nordic Bourdieu organisation (www.hexis.dk) which publishes the journal www.praktiskegrunde.dk, and co-leads the Danish-Norwegian network on trauma rehabilitation (www.phlegethon.net). His scholarly impact extends to policy engagement, particularly through his widely discussed 2023 feature article on integrating foreign medical professionals into the Danish healthcare system.

• Macrophage phenotypes
• Atherogenesis
• Uremia
• +5 more

Line Bisgaard serves as a Teaching Assistant Professor and Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic work spans both teaching responsibilities and active research in cardiovascular and kidney disease mechanisms, with particular focus on macrophage phenotypes in atherosclerotic plaques and the relationship between kidney disease and accelerated atherosclerosis. M.Sc., Molecular Biomedicine, University of Copenhagen (2010) Dr. Bisgaard's research program centers on two primary areas: investigating macrophage phenotype composition in atherosclerotic plaques compared to in vitro models, and examining mechanisms underlying acceleration of atherosclerosis in relation to kidney disease. She specifically explores whether development of insulin resistance explains the accelerated atherogenesis observed in kidney disease patients. Her work bridges cardiovascular biology and nephrology, with strong emphasis on molecular mechanisms and biomarker discovery. Analysis of her 15 most recent publications (2021-2025) reveals a consistent research trajectory focused on the intersection of cardiovascular disease and kidney pathology. The publications demonstrate expertise in metabolomics, biomarker identification, and molecular pathways linking kidney dysfunction to cardiovascular complications. Key recurring themes include apolipoprotein M research, macrophage biology in atherosclerosis, and metabolic signatures of disease progression. Dr. Bisgaard maintains active research collaborations across multiple institutions, as evidenced by her co-authorship on publications with researchers from diverse specialties including cardiology, nephrology, and molecular biology. Her work appears in high-impact journals such as Arteriosclerosis, Thrombosis, and Vascular Biology , Clinical Nutrition , and Atherosclerosis . Her laboratory work is conducted within the Physiology of circulation, kidney and lung research group at the Department of Biomedical Sciences, University of Copenhagen, with additional connections to the Diabetes Complications Biology department at Novo Nordisk where she conducts part of her PhD research.

• Genetic modification
• Mouse models
• CRISPR/Cas9
• +5 more

Javier Martin Gonzalez serves as a Doctor Research consultant and manager of the Transgenic Core Facility at the University of Copenhagen's Faculty of Health and Medical Sciences. With expertise in genetic modification and mouse model development, he leads a critical research support unit that provides essential services to the scientific community. His research interests center on genetic modification techniques, particularly CRISPR/Cas9 applications, mouse model development, embryonic stem cell culture and modification, and assisted reproduction technologies. The Transgenic Core Facility maintains an extensive cryobank with over 750 mouse strains, supporting researchers through embryo manipulation, stem cell derivation, and specialized breeding programs. His recent publication record demonstrates a strong focus on developmental biology, genome editing, and reproductive science, with multiple high-impact publications in 2024-2025 across journals including Cell Reports, Nature Communications, and Heliyon. His work spans from fundamental DNA repair mechanisms to applications in fertility and embryonic development. The Transgenic Core Facility under his management represents a vital resource for researchers at the University of Copenhagen, providing specialized expertise in mouse model generation and maintenance that supports numerous research projects across the institution.

Martin RoursgaardView profile

Associate Professor

• Toxicology
• Environmental Health
• Particle toxicology
• +9 more

Martin Roursgaard serves as an Associate Professor in the Department of Public Health at the University of Copenhagen's Faculty of Health and Medical Sciences. His primary affiliation is with the Section of Environmental Health, where he conducts research on the toxicological effects of environmental exposures with particular focus on particle toxicology and nanomaterials. His research interests center on mechanisms of action of environmental agents , utilizing cell cultures, experimental laboratory models, and controlled human exposures. Key research areas include: particle toxicology, nanoplastics, microplastics, oxidative stress, DNA damage, and cell-particle interactions. His work specifically investigates pulmonary and cardiovascular effects of environmental exposures through advanced in vitro model systems. Analysis of his recent publications reveals a consistent focus on nanoparticle and air pollution toxicology, with particular emphasis on oxidative stress mechanisms and cellular damage pathways. His research demonstrates strong collaboration with environmental health researchers across multiple institutions, as evidenced by co-authorship patterns in his 71 research outputs. Roursgaard's laboratory work prominently features in vitro models for studying cell-cell interactions and cellular responses to environmental particles. His research program aims to develop better models for understanding exposure assessment, susceptibility, and biological effects while advancing alternatives to animal experimentation.

• Food Microbiology
• Gut Health
• Fermentation Science
• +5 more

Veronica Marie Sinotte holds dual academic positions as a Postdoc at the Globe Institute's Section for Hologenomics and Assistant Professor in the Department of Food Science at the University of Copenhagen, specializing in Food Microbiology, Gut Health, and Fermentation. Her interdisciplinary research integrates natural history, hologenomics, and ethnographic knowledge to investigate microbial ecology in fermented foods and insect symbioses. Her research program centers on three pillars: Elucidating origins and ecologies of microbes in fermented foods Studying microbial symbioses of animals/plants in fermentation practices Using immersive storytelling to translate scientific knowledge to the public Current projects extend her PhD work on evolutionary relationships between microbes and social insect hosts (ants, termites, bees) to explore traditional fermentation practices involving insects or plants. Analysis of her 9 recent publications (2020-2025) reveals a research trajectory evolving from foundational studies on termite gut microbiomes and social insect symbiosis toward applied food microbiology. Key themes include microbial transmission mechanisms, host-microbe coevolution, and microbiome responses to environmental stressors, with increasing focus on fermented food systems and public science communication through initiatives like the Microbial Connections Podcast. Her collaborative network includes prominent researchers such as Rob Dunn (North Carolina State University), Sandra Breum Andersen (University of Copenhagen), and international partners across Germany and Denmark. Current projects involve the Center for Evolutionary Hologenomics and Novo Nordisk Center for Biosustainability.

• Cell Biology
• Genome stability
• DNA Damage Response
• +2 more

Saskia Hoffmann is an Associate Professor at the Novo Nordisk Foundation Center for Protein Research (CPR) at the University of Copenhagen, where she leads research in the Mailand Group. She has held this position since October 2019 and maintains dual affiliation as both Associate Professor and Guest Researcher at CPR. Her academic credentials include: PhD in Biochemistry (2013-2016) from the University of Copenhagen, CPR, under Professor Niels Mailand with thesis on 'Functions of ubiquitin ligases in responses to replication stress and DNA damage' Master's in Biochemistry (2010-2012) from the University of Copenhagen supervised by Associate Professor Claus Storgaard Sørensen Bachelor's in Biochemistry (2007-2010) from the University of Leipzig, Germany, supervised by Professor Kurt Engeland Dr. Hoffmann's research program focuses on cellular responses to DNA damage and replication stress, with particular emphasis on understanding how cells counteract genotoxic insults to maintain genome stability. Her current work investigates the molecular link between human proteases and cellular surveillance pathways, revealing critical implications for human health and disease. Her research spans: Cell Biology mechanisms underlying genome maintenance Genome stability preservation pathways DNA Damage Response systems DNA Replication processes under stress conditions Protease functions in cellular surveillance Analysis of her publication record demonstrates a consistent research trajectory focused on DNA damage response mechanisms, protein modification systems (particularly ubiquitination and SUMOylation), and their roles in maintaining genome integrity. Her work frequently explores how defects in these pathways contribute to human diseases including genetic disorders and cancer, with several publications appearing in high-impact journals such as Nature Structural and Molecular Biology, Nature Communications, and Molecular Cell. Dr. Hoffmann has established herself as a significant contributor to the field of genome maintenance research, with her work on proteases and DNA damage response pathways opening new avenues for understanding disease mechanisms and potential therapeutic approaches.

• Cardiac Arrhythmia
• Gap junctions
• Conductance disturbances
• +5 more

Morten Schak Nielsen is an Associate Professor at the Department of Biomedical Sciences within the Faculty of Health Sciences at the University of Copenhagen. He serves as head of the Gap Junction Group and has maintained a continuous academic career at the university since 1999, progressing from Assistant research professor to his current position. His educational background includes: 1994: Cand.scient. (M.Sc.) in biology 1999: Ph.D. Scient. Dr. Nielsen's primary research focuses on cardiac electrophysiology and cellular communication mechanisms in the heart. His work centers on understanding the role of gap junctions and pannexin channels in cardiac conduction and arrhythmogenesis. He investigates how conductance disturbances associated with ischemia, metabolic syndrome and diabetes contribute to cardiac dysfunction. His research employs a multidisciplinary approach combining molecular biology, electrophysiology, and advanced imaging techniques to unravel the complex mechanisms underlying cardiac conduction abnormalities. The Gap Junction Group he leads has established important connections between cellular communication structures and clinical cardiac conditions. Analysis of Dr. Nielsen's publication record reveals consistent contributions to understanding cardiac conduction mechanisms. His work spans fundamental channel physiology to clinical implications, with particular emphasis on how intercellular communication structures like gap junctions and pannexin channels function under pathological conditions. Recent publications demonstrate growing interest in mitochondrial pannexin channels and their role in ischemia-reperfusion injury, as well as detailed investigations of the intercalated disc as a critical structure for cardiac function. His research bridges basic science with potential clinical applications in cardiac arrhythmia treatment. Dr. Nielsen serves as a dedicated educator and PhD supervisor with extensive teaching experience across multiple levels: Pregraduate: Course in Excitable Cells, Course in Heart and Lungs, Human Anatomy and Systems Physiology, Cardiac Physiology Postgraduate: Cardiac Physiology, Cardiovascular Summer School, Cardiac arrhythmias: Pathophysiological mechanisms and interventions He has held significant administrative roles including Chairman of the Danish Cardiovascular Research Academy (2011-2018) and Chairman of the cardiovascular graduate program under the PhD school of Health Sciences. Dr. Nielsen maintains active roles in the scientific community as a reviewer for journals including Heart Rhythm, Pflügers Archiv, and Clinical and Experimental Pharmacology and Physiology, and has participated in organizing major international conferences on gap junctions and cardiovascular physiology.

Sisse Rye OstrowskiView profile

Clinical Professor

• Personalized medicine
• Genomic studies
• Biomarker research
• +5 more

Sisse Rye Ostrowski serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. She also holds the position of Senior Research Consultant for the Master of Personalized Medicine program. Her research focuses on translational medicine through large-scale biobanks and genomic/multiomic/biomarker cohort studies with particular emphasis on sex differences and inflammation in complex diseases. Her research interests span personalized medicine, large-scale genetic and biomarker studies, translational research, sex-differences in inflammation and disease, and immunopathogenesis of immune dysfunction. She has published extensively with 391 research outputs including 369 journal articles, 7 letters, 6 reviews, and other scholarly works. Analysis of her recent publications reveals a strong focus on genomic studies across multiple disease areas including dermatology, cardiology, HIV complications, transplantation medicine, and cancer. Her work frequently involves large-scale collaborative projects utilizing Danish biobanks and population studies, with particular attention to sex-specific differences in disease mechanisms and biomarker discovery. As a Senior Research Consultant for the Master of Personalized Medicine, she contributes to advanced training in precision medicine approaches. Her extensive publication record demonstrates leadership in multi-disciplinary research teams spanning immunology, genetics, and clinical medicine.

• Protein formulation
• Biopharmaceutical stability
• Drug delivery systems
• +5 more

Lene Jørgensen is an Associate Professor at the Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen since 2010. Previously, she served as Assistant Professor at the Department of Pharmaceutics and Analytical Chemistry, Faculty of Pharmaceutical Sciences, University of Copenhagen from 2005 to 2010. She holds a PhD degree from the Danish University of Pharmaceutical Sciences (2004) and a Cand. Pharm. degree. Her educational background includes: PhD from the Danish University of Pharmaceutical Sciences (2004) Cand. Pharm. degree Dr. Jørgensen's research focuses on the analysis of structure and stability of biomacromolecules in pharmaceutical processes and formulations. Her work examines how formulation affects protein stability and addresses regulatory aspects of protein product design and production. She specializes in protein formulation, drug delivery systems, and characterization techniques including FTIR, fluorescence, and dynamic light scattering. Her research has significant implications for developing stable biopharmaceutical products with proper functionality. Her publication record shows a consistent focus on protein and peptide stability in pharmaceutical formulations. Over the years, her research has evolved from fundamental studies on protein adsorption to more applied research on excipient selection for protein stabilization. Recent work emphasizes freeze-drying technologies and the chemical space of excipients for biopharmaceutical formulations. Her publications demonstrate expertise in bridging theoretical understanding with practical pharmaceutical development challenges, with several highly cited works including one with over 100 citations. Dr. Jørgensen actively supervises thesis projects for students in pharmacy, MPS, MIND and MRA programs. She teaches BA projects in Pharmacy and Master courses at MIND and/or MRA. Her academic service includes extensive peer review of manuscripts (30 instances mentioned) and various lecture and teaching activities both within and outside the university. Her research group focuses on pharmaceutical formulation science, particularly for biopharmaceuticals. The work involves characterization of protein behavior at interfaces, development of stable protein formulations, and investigation of novel excipients for biopharmaceutical delivery systems. Her research has practical applications as evidenced by being referenced in 72 patents, indicating significant industry impact.

Kim Theilgaard-MønchView profile

Associate Clinical Professor

• Acute Myeloid Leukemia
• Leukemic Stem Cells
• Hematopoietic Stem Cells
• +5 more

Kim Theilgaard-Mønch is an Associate Professor and Clinical Associate Professor at the Department of Clinical Medicine, University of Copenhagen. He serves as Group Leader of Theilgaard Group at the Finsen Laboratory, Rigshospitalet, and holds a combined clinical and research position as Senior Consultant in the Department of Hematology at Rigshospitalet. His work spans the Biotech Research and Innovation Centre, Program for Translational Hematology, DanStem, and the NNF Center for Stem Cell Research at the University of Copenhagen. Dr. Theilgaard-Mønch received his medical education from the University of Heidelberg in 1992, followed by an ECFMG certificate in 1994. He earned his DMSc from Rigshospitalet and the University of Copenhagen in 2007, and became board certified as a specialist in Internal Medicine & Hematology in 2017. His primary research focuses on Acute Myeloid Leukemia (AML) and hematopoietic stem cells, with particular emphasis on leukemic stem cells and clinical trials. His current research involves identifying and therapeutically targeting oncogenic signaling and DNA damage response pathways in preclinical AML models, developing novel antibody-drug conjugate therapies targeting leukemic stem cells, and applying human hematopoietic stem cell markers for refining HSC phenotypes and producing purified stem cell grafts. He is particularly interested in normal and malignant hematopoietic/myeloid development. Analysis of Dr. Theilgaard-Mønch's extensive publication record (70 research outputs) reveals a strong focus on translational hematology and AML research. His work spans molecular mechanisms of AML pathogenesis, therapeutic targeting strategies, stem cell biology, and clinical trial design. Key themes include DNA damage response pathways, signaling inhibition, stem cell markers, and treatment optimization for AML patients, with significant contributions to understanding venetoclax resistance mechanisms and novel therapeutic approaches. Dr. Theilgaard-Mønch serves as the sponsoring Principal Investigator for a translational exploratory investigator-initiated AML trial conducted in collaboration with 14 Nordic AML centers. This trial performs comprehensive AML profiling including genomics, transcriptomics, phosphoproteomics, and ex vivo drug screening to identify novel drug combinations targeting therapy-resistant minimal residual disease and leukemic stem cells. His research has been supported by a Novo Nordisk clinical research scholarship from 2013-2017. He leads Theilgaard Group, which is part of the Finsen Laboratory at Rigshospitalet and the Biotech Research and Innovation Centre at the University of Copenhagen. The group maintains strong collaborations with the Nordic AML Group and has established research networks across multiple institutions, with significant external collaboration at the country/territory level. His work bridges basic science and clinical application, with emphasis on translating laboratory findings into improved patient outcomes for AML.

• Cardiology
• HIV Research
• Infectious Diseases
• +3 more

Jesper James Linde serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with clinical duties anchored at Region Hovedstaden (Capital Region of Denmark). His institutional address at Blegdamsvej 3, Copenhagen N, places him within the university's Panum Institute complex. His research program critically examines cardiovascular complications in HIV-positive populations, specifically investigating subclinical cardiac dysfunction through large-scale epidemiological studies. Methodologically, he integrates advanced cardiac imaging with longitudinal clinical data to uncover subtle left ventricular impairments even among virally suppressed patients. This work bridges infectious disease management and cardiology, highlighting underrecognized cardiovascular risks in modern HIV care. Recent scholarship demonstrates consistent focus on HIV-associated cardiac pathology, with his 2024 European Heart Journal publication establishing significant links between HIV infection and subclinical ventricular dysfunction despite effective antiretroviral treatment. This research trajectory indicates growing emphasis on long-term organ-specific complications in chronic HIV management.

• Soil Ecology
• Microbial Ecology
• Environmental Microbiology
• +3 more

Jonathan Donhauser serves as an Assistant Professor in the Department of Biology at the University of Copenhagen, specializing in Terrestrial Ecology. His research investigates soil-ecosystem interactions with a focus on microbial communities and environmental change. Research interests encompass: Soil ecology and biogeochemistry Microbial community responses to aridity and elevation Greenhouse gas fluxes and soil organic matter dynamics Bioinformatic tool development for microbial trait modeling Methodological innovations in soil DNA extraction His recent publications (2023-2025) emphasize methodological advances and climate change impacts on soil functions. Key themes include the development of the R package MicEnvMod, analysis of Europe-wide forest soils, and the role of soil properties in mediating microbial activity and ecosystem services. Scientific awards: None mentioned. Advising and grants: No information provided. Dr. Donhauser maintains active collaborations across European institutions, contributing to international research networks in soil science and ecology.

• Neuroscience
• Psychiatry
• Mood Disorders
• +4 more

Julian Macoveanu serves as a Guest Researcher at the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His research program focuses on the neural mechanisms underlying mood disorders, particularly examining brain structure-function relationships in bipolar disorder and major depressive disorder using advanced neuroimaging techniques. Dr. Macoveanu's research interests span clinical neuroscience with emphasis on: Neural correlates of cognitive impairment in mood disorders Brain structural and functional changes associated with psychiatric conditions Neural predictors of treatment response to interventions like electroconvulsive therapy Emotion regulation processes in bipolar disorder Longitudinal brain changes in psychiatric populations and their relatives His recent publication record demonstrates a cohesive research trajectory investigating how specific brain regions (particularly amygdala and hippocampal structures) relate to clinical symptoms and treatment outcomes. Dr. Macoveanu employs sophisticated fMRI methodologies to examine both structural and functional neural characteristics across multiple patient populations. Dr. Macoveanu maintains an active research profile with multiple publications appearing in high-impact psychiatric journals including Journal of Affective Disorders, Bipolar Disorders, and Acta Psychiatrica Scandinavica. His work frequently appears with significant social media engagement and academic readership as indicated by X (Twitter) mentions and Mendeley reader counts. His research collaborations extend across multiple departments at the University of Copenhagen, particularly working with clinical psychiatry researchers to bridge neuroimaging findings with clinical applications. Dr. Macoveanu's work contributes to the growing understanding of neural biomarkers that could potentially inform more personalized treatment approaches for mood disorders.

• Psychopharmacology
• Cognitive Psychology
• Clinical Psychology
• +3 more

Jon Lansner serves as an External Lecturer at the Study Board of Psychology, University of Copenhagen, with office location at Øster Farimagsgade 2A, Copenhagen. His academic profile centers on the intersection of psychopharmacology and cognitive neuroscience, with particular emphasis on antidepressant effects on cognitive functions and memory systems. His research portfolio demonstrates deep engagement with: SSRI pharmacology and its impact on visual perception thresholds Development and validation of cognitive assessment instruments Neurobehavioral effects of antenatal depression and medication exposure Attentional mechanisms and neural correlates of cognitive processing Clinical applications of cognitive testing in psychiatric populations Methodological approaches in psychopharmacological research Analysis of his publication timeline (2016-2025) reveals consistent specialization in randomized controlled trials examining SSRI effects on perceptual and memory systems, complemented by systematic reviews addressing perinatal psychiatric interventions. His work bridges clinical practice with fundamental cognitive neuroscience through rigorous experimental designs and cross-disciplinary collaboration. Dr. Lansner maintains active research collaborations with prominent neuroscience groups at the University of Copenhagen, including investigators from the Department of Neuroscience and Clinical Pharmacology units. While specific funding sources aren't detailed in available records, his publication record indicates sustained research activity through university-affiliated projects. His institutional role within the Psychology Study Board involves academic governance and curriculum oversight for psychology programs at the University of Copenhagen, contributing to educational standards while maintaining active research engagement.

• Neurosurgery
• Brain Tumor Research
• Glioblastoma Immunotherapy
• +5 more

Jane Skjøth serves as Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Neurosurgery. Her clinical and research activities are centered at Copenhagen University Hospital (Region Hovedstaden) where she maintains an active neurosurgical practice focusing on brain tumor management. Her research program spans multiple critical areas in neuro-oncology, with emphasis on glioblastoma immunotherapy , intraoperative imaging techniques , and blood-brain barrier dynamics . Current projects include developing novel optical imaging agents for fluorescence-guided glioma resection and investigating immune checkpoint inhibitor mechanisms in recurrent glioblastoma. Her work integrates translational approaches from proteomic analysis of cerebrospinal fluid to first-in-human surgical imaging trials. Analysis of her recent publication portfolio reveals strong focus on translational neurosurgical oncology , particularly in three interconnected domains: (1) Advanced intraoperative visualization techniques for tumor resection, (2) Immunological mechanisms and therapeutic responses in glioblastoma, and (3) Metabolic and physiological monitoring during brain tumor surgery. Her collaborative network spans neurosurgery, oncology, and molecular imaging disciplines across Danish and international institutions. While specific mentoring activities aren't detailed in available sources, her leadership in first-in-human surgical imaging trials and multi-institutional glioblastoma cohort studies indicates active supervision of clinical researchers. Her work has attracted significant scientific attention with multiple publications picked up by news outlets and substantial academic readership.